Is COSRF or MRK a better dividend investment in 2026?

COSRF currently yields 2758.62% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: COSRF offers higher current income.

What is the dividend yield difference between COSRF and MRK?

COSRF has a forward dividend yield of 2758.62% ($2.00/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 2755.37 percentage points.

Home › Compare › COSRF vs MRK

COSRF vs MRK: Dividend Comparison 2026

COSRF yields 2758.62% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 COSRF wins by $204719102916.85M in total portfolio value

INVESTMENT

TIME HORIZON10 years

COSRF

● Live price

2758.62%

Share price

$0.07

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$204719102916.88M

Annual income

$191,092,446,422,989,540.00

Full COSRF calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — COSRF vs MRK

📍 COSRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	COSRF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, COSRF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

COSRF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

COSRF

Annual income on $10K today (after 15% tax)

$234,482.76/yr

After 10yr DRIP, annual income (after tax)

$162,428,579,459,541,100.00/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, COSRF beats the other by $162,428,579,459,540,300.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of COSRF + MRK for your $10,000?

COSRF: 50%MRK: 50%

100% MRK50/50100% COSRF

Portfolio after 10yr

$102359551458.46M

Annual income

$95,546,223,211,495,250.00/yr

Blended yield

93.34%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

COSRF

No analyst data

Altman Z

-102.9

Piotroski

1/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

COSRF buys

MRK buys

No recent congressional trades found for COSRF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCOSRFMRK

Forward yield	2758.62% ✓	3.25%
Annual dividend / share	$2.00	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$204719102916.88M ✓	$30.7K
Annual income after 10y	$191,092,446,422,989,540.00 ✓	$950.29
Total dividends collected	$203772577950.22M ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: COSRF vs MRK ($10,000, DRIP)

Year	COSRF Portfolio	COSRF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$286,562	$275,862.07	$11,192	$351.54	+$275.4K → COSRF
2	$7,694,622	$7,388,000.49	$12,524	$392.70	+$7.68M → COSRF
3	$193,634,094	$185,400,848.81	$14,015	$438.65	+$193.62M → COSRF
4	$4,567,549,861	$4,360,361,380.00	$15,682	$489.96	+$4567.53M → COSRF
5	$101,013,124,410	$96,125,846,058.51	$17,547	$547.23	+$101013.11M → COSRF
6	$2,094,869,192,098	$1,986,785,148,979.70	$19,632	$611.16	+$2094869.17M → COSRF
7	$40,749,090,616,711	$38,507,580,581,166.02	$21,963	$682.53	+$40749090.59M → COSRF
8	$743,642,510,783,011	$700,040,983,823,130.60	$24,571	$762.18	+$743642510.76M → COSRF
9	$12,735,192,984,946,568	$11,939,495,498,408,744.00	$27,486	$851.08	+$12735192984.92M → COSRF
10	$204,719,102,916,882,340	$191,092,446,422,989,540.00	$30,745	$950.29	+$204719102916.85M → COSRF

COSRF vs MRK: Complete Analysis 2026

COSRF — Stock

Cosigo Resources Ltd. engages in the acquisition and exploration of mineral properties in Colombia and Brazil. The company primarily explores for gold deposits. Its flagship project is its 100% owned Machado Project, covering an area of 9,973 hectares located in the Taraira Gold Belt of southeastern Colombia. The company was formerly known as Cosigo Resources Inc. and changed its name to Cosigo Resources Ltd. in April 2011. Cosigo Resources Ltd. was incorporated in 1987 and is headquartered in Victoria, Canada.

Full COSRF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this COSRF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

COSRF vs SCHD COSRF vs JEPI COSRF vs O COSRF vs KO COSRF vs MAIN COSRF vs JNJ COSRF vs ABBV COSRF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.